JP2016509579A5 - - Google Patents

Download PDF

Info

Publication number
JP2016509579A5
JP2016509579A5 JP2015548837A JP2015548837A JP2016509579A5 JP 2016509579 A5 JP2016509579 A5 JP 2016509579A5 JP 2015548837 A JP2015548837 A JP 2015548837A JP 2015548837 A JP2015548837 A JP 2015548837A JP 2016509579 A5 JP2016509579 A5 JP 2016509579A5
Authority
JP
Japan
Prior art keywords
dimethyl
dione
pyrimido
dihydro
pyrrolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015548837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016509579A (ja
JP6284546B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/061043 external-priority patent/WO2014097148A1/en
Publication of JP2016509579A publication Critical patent/JP2016509579A/ja
Publication of JP2016509579A5 publication Critical patent/JP2016509579A5/ja
Application granted granted Critical
Publication of JP6284546B2 publication Critical patent/JP6284546B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015548837A 2012-12-19 2013-12-17 Cftrチャネルを阻害するための三環式化合物 Expired - Fee Related JP6284546B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261739335P 2012-12-19 2012-12-19
US61/739,335 2012-12-19
US201361906141P 2013-11-19 2013-11-19
US61/906,141 2013-11-19
PCT/IB2013/061043 WO2014097148A1 (en) 2012-12-19 2013-12-17 Tricyclic compounds for inhibiting the cftr channel

Publications (3)

Publication Number Publication Date
JP2016509579A JP2016509579A (ja) 2016-03-31
JP2016509579A5 true JP2016509579A5 (enExample) 2017-01-26
JP6284546B2 JP6284546B2 (ja) 2018-02-28

Family

ID=50030372

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015548837A Expired - Fee Related JP6284546B2 (ja) 2012-12-19 2013-12-17 Cftrチャネルを阻害するための三環式化合物

Country Status (25)

Country Link
US (2) US9359381B2 (enExample)
EP (1) EP2935278B1 (enExample)
JP (1) JP6284546B2 (enExample)
KR (1) KR20150097660A (enExample)
CN (1) CN105143230B (enExample)
AP (1) AP2015008539A0 (enExample)
AR (1) AR094122A1 (enExample)
AU (1) AU2013365739A1 (enExample)
BR (1) BR112015014292A2 (enExample)
CA (1) CA2895660A1 (enExample)
CL (1) CL2015001730A1 (enExample)
CR (1) CR20150325A (enExample)
CU (1) CU20150066A7 (enExample)
EA (1) EA201591177A1 (enExample)
ES (1) ES2628369T3 (enExample)
HK (1) HK1209741A1 (enExample)
IL (1) IL239389A0 (enExample)
MX (1) MX2015007939A (enExample)
PE (1) PE20151055A1 (enExample)
PH (1) PH12015501386A1 (enExample)
SG (1) SG11201504594QA (enExample)
TN (1) TN2015000279A1 (enExample)
TW (1) TW201429974A (enExample)
UY (1) UY35211A (enExample)
WO (1) WO2014097148A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9056867B2 (en) 2011-09-16 2015-06-16 Novartis Ag N-substituted heterocyclyl carboxamides
EP2935278B1 (en) 2012-12-19 2017-03-15 Novartis AG Tricyclic compounds for inhibiting the cftr channel
KR20150095925A (ko) 2012-12-19 2015-08-21 노파르티스 아게 Cftr 억제제로서의 트리시클릭 화합물
CN106715536B (zh) * 2014-09-19 2021-06-01 莫门蒂夫性能材料股份有限公司 用于受控的硅氧烷交联的铂(ii)二烯配合物
US9624233B2 (en) * 2015-04-23 2017-04-18 Trevi Therapeutics, Inc. Compounds for treating pruritic conditions
CN106478558B (zh) * 2016-10-17 2019-03-29 天津雅奥科技发展有限公司 一种4-羟甲基-二氢-呋喃-2(3h)-酮的合成方法
US12319686B2 (en) 2019-01-17 2025-06-03 Hoffmann-La Roche Inc. Process for the preparation of tetrahydropyridopyrimidines
CN114007623A (zh) * 2019-06-12 2022-02-01 加利福尼亚大学董事会 治疗胆汁酸性腹泻的方法
AU2022265718A1 (en) 2021-04-29 2023-11-02 Novartis Ag Deubiquitinase-targeting chimeras and related methods
CN117654560B (zh) * 2023-12-01 2024-06-04 安徽泽升科技股份有限公司 一种通过氧化氨基连续化制备硝基化合物的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2382528A1 (en) 1999-08-25 2001-03-01 Banyu Pharmaceutical Co., Ltd. Novel isoindole derivatives
JP2002255967A (ja) 2001-02-27 2002-09-11 Banyu Pharmaceut Co Ltd イソインドール誘導体を有効成分とする糖尿病の治療剤、糖尿病の慢性合併症の予防剤又は肥満の治療剤。
JP2007524596A (ja) 2003-02-28 2007-08-30 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 共結晶医薬組成物
MX2009006228A (es) 2006-12-12 2009-06-22 Schering Corp Inhibidores de aspartil proteasa.
US20110015137A1 (en) * 2007-07-05 2011-01-20 Trustees Of Boston University Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
IN2012DN00719A (enExample) * 2009-08-10 2015-06-19 Univ California
USRE48842E1 (en) * 2011-05-27 2021-12-07 The Regents Of The University Of California Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor
EP2935278B1 (en) 2012-12-19 2017-03-15 Novartis AG Tricyclic compounds for inhibiting the cftr channel
KR20150095925A (ko) 2012-12-19 2015-08-21 노파르티스 아게 Cftr 억제제로서의 트리시클릭 화합물

Similar Documents

Publication Publication Date Title
JP2016509579A5 (enExample)
KR101499308B1 (ko) 가용성 구아닐레이트 시클라제 활성화제
JP2012515205A5 (enExample)
JP2016523922A5 (enExample)
JP2017503867A5 (enExample)
JP2007523183A5 (enExample)
JP2020531498A5 (enExample)
JP2003531210A5 (enExample)
RU2006129324A (ru) Конденсированные гетероциклические соединения и их применение в качестве антагонистов метаботропных глутаматных рецепторов
JP2012515786A5 (enExample)
JP2017505762A5 (enExample)
CA2610888A1 (en) Inhibitors of akt activity
JP2010522750A5 (enExample)
RU2008137941A (ru) ПРОИЗВОДНЫЕ ОКТАГИДРОПИРРОЛО[3,4-b]ПИРРОЛА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ОКТАГИДРОПИРРОЛО[3,4-b]ПИРРОЛА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ ИЛИ НАРУШЕНИЯ СОСТОЯНИЯ ОРГАНИЗМА, ЧУВСТВИТЕЛЬНОГО К МОДУЛЯЦИИ АКТИВНОСТИ РЕЦЕПТОРА ГИСТАМИНА-3
JP2009528389A5 (enExample)
RU2011116230A (ru) Пиразолопиридиновые производные как ингибиторы надфн-оксидазы
JP2013523884A5 (enExample)
JP2018522869A5 (enExample)
JP6419800B2 (ja) Nmda受容体活性の調節因子としてのチアゾロピリミジノン
RU2016110483A (ru) Производные пирролопиридина или пиразолопиридина
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения
JP2013505930A5 (enExample)
HRP20121022T1 (hr) Kondenzirani bicikliäśki pirimidini
RU2019116251A (ru) Пиразоло[3,4-b]пиридины и имидазо[1,5-b]пиридазины в качестве ингибиторов pde1
JP2016537384A5 (enExample)